Arisaph Pharmaceuticals' Series E Round

Arisaph Pharmaceuticals raised a round of funding on November 13, 2003. Investors include Vatera Healthcare Partners.

Arisaph Pharmaceuticals, formerly Triad Pharmaceuticals, is an emerging biopharmaceutical company focused on developing therapies for cancer, cardiovascular disease and diabetes. The company utilizes …

Articles about Arisaph Pharmaceuticals' Series E Round: